$FHLD
Freedom Holdings, Inc.

2024 Q3 Form 10-Q Financial Statement

#000147793224005122 Filed on August 19, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $16.00
YoY Change -98.26%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $265.6K
YoY Change -24.87%
Operating Profit -$265.6K
YoY Change -24.87%
Interest Expense $2.863K
YoY Change -2.35%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$234.4K
YoY Change -34.23%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 58.41M shares 55.31M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $2.184K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $2.184K
YoY Change 642.86%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.184K
Total Long-Term Assets $0.00
Total Assets $2.184K
YoY Change 642.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.90K
YoY Change -52.97%
Accrued Expenses $240.0K
YoY Change -0.68%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $272.8K
YoY Change -16.56%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $272.8K
Total Long-Term Liabilities
Total Liabilities $395.2K
YoY Change -4.75%
SHAREHOLDERS EQUITY
Retained Earnings -$10.43M
YoY Change 2.58%
Common Stock $5.841K
YoY Change 5.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$393.0K
YoY Change
Total Liabilities & Shareholders Equity $2.184K
YoY Change 642.86%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$234.4K
YoY Change -34.23%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Assets Current
AssetsCurrent
2184 usd
CY2024Q2 us-gaap Assets
Assets
2184 usd
CY2023Q3 us-gaap Assets
Assets
588 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
22897 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
44500 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
8950 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
330 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
240000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
241297 usd
CY2024Q2 us-gaap Liabilities
Liabilities
395210 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
5841 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
5531 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10029518 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9765828 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-356452 usd
us-gaap Net Income Loss
NetIncomeLoss
-255137 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
272847 usd
CY2024Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
122363 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-17435 usd
CY2023Q3 us-gaap Liabilities
Liabilities
412477 usd
us-gaap Interest Expense
InterestExpense
8620 usd
us-gaap Interest Expense
InterestExpense
8942 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001386044
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54853
dei Entity Registrant Name
EntityRegistrantName
FREEDOM HOLDINGS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
56-2560951
dei Entity Address Address Line1
EntityAddressAddressLine1
10524 Independence Ave
dei Entity Address City Or Town
EntityAddressCityOrTown
Chatsworth
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
91311
dei City Area Code
CityAreaCode
818
dei Local Phone Number
LocalPhoneNumber
357-3155
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
58408825 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2184 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
588 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
588 usd
CY2024Q2 fhld Due To Related Party Current
DueToRelatedPartyCurrent
1000 usd
CY2023Q3 fhld Due To Related Party Current
DueToRelatedPartyCurrent
0 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
286127 usd
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
126350 usd
CY2024Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
58408825 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55308825 shares
CY2024Q2 fhld Subscription Receivable
SubscriptionReceivable
4500 usd
CY2023Q3 fhld Subscription Receivable
SubscriptionReceivable
-5500 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10432885 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10177748 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-393026 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-411889 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2184 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
588 usd
CY2024Q2 us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2024Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
254000 usd
CY2023Q2 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
351000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
254000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
351000 usd
CY2024Q2 us-gaap Professional Fees
ProfessionalFees
11569 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
1599 usd
us-gaap Professional Fees
ProfessionalFees
26364 usd
us-gaap Professional Fees
ProfessionalFees
29647 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
921 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
153 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3556 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
265585 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
353520 usd
us-gaap Operating Expenses
OperatingExpenses
280517 usd
us-gaap Operating Expenses
OperatingExpenses
384203 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-265585 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-353520 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-280517 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-384203 usd
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
34000 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
34000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
2863 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
2932 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-234448 usd
us-gaap Net Income Loss
NetIncomeLoss
-393145 usd
CY2024Q2 fhld Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
CY2023Q2 fhld Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
fhld Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.00
fhld Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
CY2024Q2 fhld Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
58191243 shares
CY2023Q2 fhld Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
50056078 shares
fhld Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
56488752 shares
fhld Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
31096371 shares
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-412471 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-5199 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-417670 usd
CY2023Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
30000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-31494 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-419164 usd
CY2023Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
5000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
351000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-356452 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-414616 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-411889 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-3254 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-415143 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-427578 usd
CY2024Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
10000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
254000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-234448 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-393026 usd
us-gaap Profit Loss
ProfitLoss
-255137 usd
us-gaap Profit Loss
ProfitLoss
-393145 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
254000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
351000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
34000 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
11100 usd
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
1996 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
8620 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-253 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15417 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-40402 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-3987 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-4306 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
4825 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
35000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
20000 usd
us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
5000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
17013 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
40519 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1596 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
117 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
588 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
177 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2184 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
294 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
6153 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">We maintain our cash in bank deposit accounts, the balances of which at times may exceed federally insured limits. We continually monitor our banking relationships and consequently have not experienced any losses in our accounts. We believe we are not exposed to any significant credit risk on cash. </p>
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2184 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
588 usd
us-gaap Share Based Compensation
ShareBasedCompensation
254000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
351000 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-10432885 usd
us-gaap Net Income Loss
NetIncomeLoss
-255137 usd
CY2017Q3 us-gaap Unsecured Debt
UnsecuredDebt
50000 usd
CY2017Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.15 pure
CY2023Q4 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
750 usd
CY2024Q2 us-gaap Interest Payable Current
InterestPayableCurrent
8950 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
330 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
131313 usd
CY2023Q3 us-gaap Notes Payable
NotesPayable
126680 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
240000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
241297 usd
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
58408825 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55308825 shares

Files In Submission

Name View Source Status
0001477932-24-005122-index-headers.html Edgar Link pending
0001477932-24-005122-index.html Edgar Link pending
0001477932-24-005122.txt Edgar Link pending
0001477932-24-005122-xbrl.zip Edgar Link pending
fhld-20240630.xsd Edgar Link pending
fhld_10q.htm Edgar Link pending
fhld_ex311.htm Edgar Link pending
fhld_ex312.htm Edgar Link pending
fhld_ex321.htm Edgar Link pending
fhld_ex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fhld-20240630_cal.xml Edgar Link unprocessable
fhld-20240630_def.xml Edgar Link unprocessable
fhld-20240630_lab.xml Edgar Link unprocessable
fhld-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
fhld_10q_htm.xml Edgar Link completed